142 related articles for article (PubMed ID: 36932968)
21. Addition of radiotherapy to surgery and chemotherapy improves survival in localized malignant pleural mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) study.
Thompson AB; Quinn TJ; Siddiqui ZA; Almahariq MF; Grills IS; Stevens CW
Lung Cancer; 2020 Aug; 146():120-126. PubMed ID: 32531717
[TBL] [Abstract][Full Text] [Related]
22. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
[TBL] [Abstract][Full Text] [Related]
23. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
Nelson DB; Rice DC; Niu J; Atay SM; Vaporciyan AA; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao AS; Gomez DR; Giordano SH; Mehran RJ; Sepesi B
Eur J Cardiothorac Surg; 2018 May; 53(5):960-966. PubMed ID: 29211849
[TBL] [Abstract][Full Text] [Related]
24. Management of Malignant Pleural Mesothelioma in the Elderly Population.
Verma V; Wegner RE; Ludmir EB; Hasan S; Colonias A; Grover S; Friedberg JS; Simone CB
Ann Surg Oncol; 2019 Aug; 26(8):2357-2366. PubMed ID: 31011908
[TBL] [Abstract][Full Text] [Related]
25. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
[TBL] [Abstract][Full Text] [Related]
26. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
[TBL] [Abstract][Full Text] [Related]
27. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
[TBL] [Abstract][Full Text] [Related]
28. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
Damhuis RA; Khakwani A; De Schutter H; Rich AL; Burgers JA; van Meerbeeck JP
Lung Cancer; 2015 Aug; 89(2):212-7. PubMed ID: 26044908
[TBL] [Abstract][Full Text] [Related]
29. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
[TBL] [Abstract][Full Text] [Related]
30. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
Zhuo M; Zheng Q; Chi Y; Jia B; Zhao J; Wu M; An T; Wang Y; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Wang J; Zhai X; Wang Z
Thorac Cancer; 2019 May; 10(5):1193-1202. PubMed ID: 30951250
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
[TBL] [Abstract][Full Text] [Related]
32. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
Alnajar A; Kareff SA; Razi SS; Rao JS; De Lima Lopes G; Nguyen DM; Villamizar N; Rodriguez E
JAMA Netw Open; 2023 Mar; 6(3):e234261. PubMed ID: 36951862
[TBL] [Abstract][Full Text] [Related]
33. Pediatric, Adolescent and Young Adult (AYA) Peritoneal and Pleural Mesothelioma: A National Cancer Database Review.
Nofi CP; Roberts BK; Rich BS; Glick RD
J Pediatr Surg; 2024 Jun; 59(6):1113-1120. PubMed ID: 38418273
[TBL] [Abstract][Full Text] [Related]
34. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
van Kooten JP; Belderbos RA; von der Thüsen JH; Aarts MJ; Verhoef C; Burgers JA; Baas P; Aalbers AGJ; Maat APWM; Aerts JGJV; Cornelissen R; Madsen EVE
Thorax; 2022 Dec; 77(12):1260-1267. PubMed ID: 35149582
[TBL] [Abstract][Full Text] [Related]
35. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population.
Flores RM; Riedel E; Donington JS; Alago W; Ihekweazu U; Krug L; Rosenzweig K; Adusumilli PS; Carbone M; Pass HI
J Thorac Oncol; 2010 Oct; 5(10):1649-54. PubMed ID: 20871264
[TBL] [Abstract][Full Text] [Related]
36. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
Mezei G; Chang ET; Mowat FS; Moolgavkar SH
Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
[TBL] [Abstract][Full Text] [Related]
37. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
38. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
39. Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation.
Hasan B; Greillier L; Pallis A; Menis J; Gaafar R; Sylvester R; Fennell DA; Baas P; Surmont V; Van Meerbeeck JP; O'brien ME
Eur J Cancer; 2014 Nov; 50(16):2771-82. PubMed ID: 25155251
[TBL] [Abstract][Full Text] [Related]
40. Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
de Boer NL; van Kooten JP; Damhuis RAM; Aerts JGJV; Verhoef C; Madsen EVE
Ann Surg Oncol; 2019 Dec; 26(13):4222-4228. PubMed ID: 31620941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
